MENU

FATE Fate Therapeutics Forecast, Technical & Fundamental Analysis

a clinical stage biopharmaceutical company

Industry Biotechnology
FATE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
FATE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

FATE is expected to report earnings to rise 9.42% to -43 cents per share on March 03

Fate Therapeutics FATE Stock Earnings Reports
Q4'24
Est.
$-0.44
Q3'24
Beat
by $0.02
Q2'24
Beat
by $0.13
Q1'24
Beat
by $0.01
Q4'23
Beat
by $0.07
The last earnings report on November 12 showed earnings per share of -40 cents, beating the estimate of -41 cents. With 456.18K shares outstanding, the current market capitalization sits at 214.12M.
A.I. Advisor
published General Information

General Information

a clinical stage biopharmaceutical company

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
12278 Scripps Summit Drive
Phone
+1 858 875-1800
Employees
220
Web
https://www.fatetherapeutics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME31.261.82
+6.18%
GameStop Corp
TSLA479.8616.84
+3.64%
Tesla
AAPL253.482.44
+0.97%
Apple
BTC.X106140.600000110.890625
+0.10%
Bitcoin cryptocurrency
SPY604.29-2.50
-0.41%
SPDR® S&P 500® ETF Trust

FATE and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, FATE has been loosely correlated with ALLO. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if FATE jumps, then ALLO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FATE
1D Price
Change %
FATE100%
-6.00%
ALLO - FATE
58%
Loosely correlated
+0.49%
RCKT - FATE
52%
Loosely correlated
+1.36%
NTLA - FATE
51%
Loosely correlated
-1.87%
CRBU - FATE
50%
Loosely correlated
+1.57%
BEAM - FATE
50%
Loosely correlated
-1.21%
More